Integra LifeSciences Corporation

Integra LifeSciences Corporation is classified under Medical Devices (Healthcare).

Integra LifeSciences has a broad portfolio of innovative products and solutions used in neurosurgery, wound reconstruction and care, surgical reconstruction, surgical instrumentation and lighting, and ear, nose and…

Public location fields place operations in Plainsboro, New Jersey, United States.

See organisations in the same geography via Geo-Intelligence.

Leadership details are not listed in the current public record for Integra LifeSciences Corporation.

No verified relationship is present in the current dataset. Absence of names is not evidence that the organisation has no officers or affiliates.

The strongest verified public signals for Integra LifeSciences Corporation are industry Medical Devices, location Plainsboro, New Jersey, United States, security letter grade B (85/100), and founded 2017.

The security grade is one OrgIntel dimension, not a substitute for vendor, reputation, or threat evidence.

Related public lenses: Risk, Vendor, and Brand.

For counterparties evaluating Integra LifeSciences Corporation, the public dossier is a first-pass identity and context check in Medical Devices based in Plainsboro, New Jersey, United States.

The available letter grade B (85/100) is a stakeholder-relevant outside-in signal, not a credit, legal, or financial rating.

Use the canonical organization profile when you need the full public assessment record.

Considerations for Integra LifeSciences Corporation split across identity completeness, Medical Devices operating context, and any scored cyber signal.

Cyber is present as letter grade B (85/100). Vendor dependencies, reputation themes, and threat actors are not inferred on this page unless those modules publish verified evidence.

Continue in Risk Intelligence for exposure-focused follow-up.

For Integra LifeSciences Corporation, confirm domain-to-entity mapping, and any names used in contracts.

The public preview still lacks leadership; those should be collected from the organisation or a full audit rather than filled with assumptions.

The most relevant next step for Integra LifeSciences Corporation is to open the full organization profile and decide whether Corporate, Risk, or Vendor intelligence answers the remaining diligence questions.

The existing grade is enough for triage; authenticated monitoring is the follow-on if this organisation will sit in a portfolio.